- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| Do | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 09.07. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Bone Biologics enters into definitive agreement for $3.0M private placement | 1 | Seeking Alpha | ||
| 08.07. | BONE BIOLOGICS CORPORATION: Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 118 | GlobeNewswire (Europe) | BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics," or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 19.05. | Bone Biologics extends rhNELL-1 protein shelf life to 29 months | 1 | Investing.com | ||
| 19.05. | Bone Biologics verlängert Haltbarkeit von Protein rhNELL-1 auf 29 Monate | 1 | Investing.com Deutsch | ||
| 14.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.03. | Bone Biologics kündigt 'At-the-Market'-Angebot über 1,06 Millionen US-Dollar an der NASDAQ an | 1 | Investing.com Deutsch | ||
| 13.03. | Bone Biologics Corp - 8-K, Current Report | 3 | SEC Filings | ||
| 02.03. | Bone Biologics Corp - 10-K, Annual Report | 3 | SEC Filings | ||
| 08.01. | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | 425 | GlobeNewswire (Europe) | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 23.12.25 | BONE BIOLOGICS CORPORATION: Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | 346 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,080 | -0,95 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| BUTTERFLY NETWORK | 5,765 | -0,29 % | Michael Burry sagt nur: wow: Butterfly +56 %: Die kleine Aktie hinter Midjourneys 60-Sekunden-Körperscanner | © Foto: Jaque Silva - NurPhotoMidjourney plant einen 60-Sekunden-Körperscanner per Ultraschall und KI. Butterfly liefert die Technik für den Prototyp. Anleger haben die Aktie am Donnerstag brutal hochgekauft... ► Artikel lesen | |
| BEYOND AIR | 5,705 | +2,24 % | XFRA NEW INSTRUMENTS AVAILABLE ON 13.07.2026 | The following instruments on XETRA do have their first trading 13.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 13.07.2026
Aktien
1 CY0201461213 Pelican Aqua Holding... ► Artikel lesen | |
| ACCENDRA HEALTH | 3,260 | +7,24 % | ACCENDRA HEALTH INC/VA/ - 8-K, Current Report | ||
| AXOGEN | 34,820 | -0,06 % | Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 | ||
| AETHLON MEDICAL | 0,670 | +3,48 % | Aethlon Medical, Inc.: Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier | Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts
... ► Artikel lesen | |
| AVANOS MEDICAL | 21,200 | -0,93 % | Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger | ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced... ► Artikel lesen | |
| ANGIODYNAMICS | 12,100 | -0,82 % | H.C. Wainwright raises AngioDynamics stock price target on growth | ||
| APYX MEDICAL | 3,700 | -2,63 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,440 | -0,12 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Application for quotation of securities - AVR | ||
| ADAPTHEALTH | 10,955 | -0,05 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| ENVUE MEDICAL | 0,410 | -1,42 % | ENvue Medical, Inc.: ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform | Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing... ► Artikel lesen | |
| GLUCOTRACK | 0,493 | +0,20 % | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 1,465 | +1,03 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 4,560 | +2,47 % | Autonomix Medical, Inc.: Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform | Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen |
BONE BIOLOGICS CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,150 Euro und damit -1,71 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.